Expertise in
5
conditions

Cyrus Khandanpour

Ratzeburger Allee 160, 
Luebeck, SH, DE 
Expertise in
5
conditions
Ratzeburger Allee 160, 
Luebeck, SH, DE 

Overview

Cyrus Khandanpour practices practicing medicine in Luebeck, Germany.

Mr. Khandanpour is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndrome (MDS), and Bone Marrow Transplant.

He is actively involved in clinical research, co-authoring 95 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Ratzeburger Allee 160, Luebeck, SH 23538, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Multicenter, Phase 1, Open-label, Dose-escalation and Expansion Study of TNB-383B, a Bispecific Antibody Targeting BCMA in Subjects With Relapsed or Refractory Multiple Myeloma
A Multicenter, Phase 1, Open-label, Dose-escalation and Expansion Study of TNB-383B, a Bispecific Antibody Targeting BCMA in Subjects With Relapsed or Refractory Multiple Myeloma
Enrollment Status: Active_not_recruiting
Publish Date: February 06, 2026
Intervention Type: Drug
Study Drug: TNB-383B
Study Phase: Phase 1/Phase 2
Daratumumab in Combination With Bortezomib and Dexamethasone in Subjects With Relapsed or Relapsed and Refractory Multiple Myeloma and Severe Renal Impairment Including Subjects Undergoing Hemodialysis: A Phase 2, Open-label, Multicenter Trial
Daratumumab in Combination With Bortezomib and Dexamethasone in Subjects With Relapsed or Relapsed and Refractory Multiple Myeloma and Severe Renal Impairment Including Subjects Undergoing Hemodialysis: A Phase 2, Open-label, Multicenter Trial
Enrollment Status: Completed
Publish Date: May 31, 2022
Intervention Type: Drug
Study Drugs: Daratumumab, Bortezomib, Dexamethasone
Study Phase: Phase 2
View 1 Less Clinical Trial

95 Total Publications

Real-world analyses of bispecific antibodies and CAR-T cell therapy in relapsed or refractory multiple myeloma: a global TriNetX discovery and contemporary validation cohort.
Real-world analyses of bispecific antibodies and CAR-T cell therapy in relapsed or refractory multiple myeloma: a global TriNetX discovery and contemporary validation cohort.
Journal: Leukemia & lymphoma
Published: July 28, 2026

Frequently Asked Questions about Cyrus Khandanpour

Is Cyrus Khandanpour a top-rated expert for Multiple Myeloma?

MediFind is an objective health platform that identifies experts based on real-world data. Cyrus Khandanpour is classified as an Distinguished expert for Multiple Myeloma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Cyrus Khandanpour participate in research or clinical trials?

Yes. Cyrus Khandanpour has published 95 articles and abstracts on conditions like Multiple Myeloma. You can view a list of Cyrus Khandanpour's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Khandanpour's expertise for a condition
ConditionClose
    View All 15 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile